Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://www.utsouthwestern.edu/newsroom/articles/year-2022/june-rapid-covid-test.html
these tests for biosurvallance are interesting
Looks great! Also think it’s going to see 5$ soon. We added more shares today
I saw two people getting massages in an XpresSpa today!
#whenlambo?
ah how I feel all sore!
Big headache, very high fever! Think if I was not vaccinated!
Heavy the "coviddi"!
I can't even focus what I see ... let's break through 1.54!
In my family they are all positive!
I stay out but I feel broken bones and shivering! Maybe soon it will be my turn too: I am fully vaccinated, so don't worry!
In a month there will be intensive care full of unvaccinated!
natural selection!
Residues of Neanderthal homo still remain and they are probably shorts here!
LOL
hearing xspa will be getting a bigger cdc contract this month or APRIL. with earnings report that was outstanding this stock has a possible huge move to 5 again soon.
we are buying 500 thousand shares today. company buyback this week and covid surging could see this stock over 2 very soon.
Come on give us fireworks!!!!
Pump it!
Scott has earned leadership on the field!
Now it is clear why they put him in charge!
Ridiculous MC
between assets and cash it should quote double!
Come on, it seems that peace is coming ... Covid mutations start again ...
it looks bad for the shorts!
unreal!
I guess someone is pissed off!
things did not go as expected! IMO warrants mean nothing!
Here things did not go as they should go!
And then, again! How the fuck were they supposed to go?
Instead it seems to me that here there is a great desire to take every good opportunity to make money!
They have a lot of liquidity from them!
Major CDC update - big impact on the title
Due to the lack of rapid tests available, the government will introduce 1 minute self-diagnosis. Put one finger of your right hand in your mouth and one finger of your left hand in your ass. After sixty seconds, You switch fingers. If you feel no taste or smell, isolate yourself!
True to all that!! Let’s see what is said during 2/7 eps release..
Don’t any shares yet, but like their biz model.
There are personal reasons! It seems that they give goodies ...
Thinking badly makes me say that it is a good excuse to bring down the price but perhaps there are serious personal reasons ...
I think I'll add
The appointment of Mr. Milford follows the resignation of Douglas Satzman as the President and Chief Executive Officer of the Company for personal reasons effective as of the same date.
In connection with Mr. Satzman’s departure, the Company expects to enter into a severance and release agreement with Mr. Satzman, providing for a severance package with Mr. Satzman, subject to Mr. Satzman executing a general release in favor of the Company, resigning as a director of the Company and otherwise complying with the terms of the severance and release agreement. In connection therewith, the Board has appointed Mr. Milford as a member of the Board with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders, contingent upon and effective immediately following Mr. Satzman’s resignation as a director.
Any idea why Satzman out( besides boiler plate ‘personal reasons’)??
New IHU variant with more omicron mutations, reported from France.
Until they invent a cure or a vaccine that works on the variants, tracking is key to stemming!
looks bad for the shorts!
I think it is better for everyone to take shares on the market!
I've been buying $2/$2.50 Options w/Call Dates Jan 21, Feb 18th, Mar 18th. The build-up to & after Feb. 15th when the 4th Qtr Earnings report is released is going to be HUGE!!!
ONLY bookings from the website:
Summary for 2022-01-03
JFK: 1296/1296 (100%)
BOS_E: 234/234 (100%)
BOS_C: 252/252 (100%)
EWR_B: 280/280 (100%)
EWR_C: 185/185 (100%)
PHX: 108/108 (100%)
DEN: 275/275 (100%)
SLC: 201/275 (73%)
IAH: 275/275 (100%)
DCA: 275/275 (100%)
IAD: 222/222 (100%)
SEA: 185/185 (100%)
SFO: 148/148 (100%)
ATL_E: 259/259 (100%)
=====================
Total = 4195 of 4269 (98%)
BIG!
I can't wait to hear that more test centers have opened!
all overbooked
yesterday on the drop I added!
and as soon as resources are released I add!
I'm still surprised, almost stunned that there's only 1 or 2 people on this board when $XSPA has been on a run the last coupla weeks, and is likely to launch into the New Year. It's guidance for this New Year is $150+ Million, given how much testing will be done at the major airports where they are set up.
The Centers for Disease Control and Prevention (CDC) last week started distributing free COVID-19 home test kits to international travelers at several airports. The CDC encourages - but does not mandate - international air travelers to get a new COVID-19 test upon arriving in the United States.
New rules took effect on Dec. 6 requiring nearly all people flying to the United States to obtain a negative COVID-19 test within one day of travel.
The CDC last month ordered airlines to disclose passenger names and other information about those who have recently been in the eight southern African countries.
I find it very odd that there's been nobody on this board the last couple of days except for 2 or 3 people. $XSPA is very much a stock that's 'happenin' and getting to be more so.
“We are actively working to scale up this collaborative post-arrival airport-based surveillance testing program to monitor for this new variant in arriving travelers.”
On Sunday, November 28, XpresCheck expanded its COVID-19 biosurveillance program to test passengers entering the United States from Southern Africa, including passengers making connections through Europe. The initial COVID-19 biosurveillance program launched in September and provided testing for travelers arriving from India at three key United States airports, John F.
Kennedy International Airport, Newark-Liberty International Airport, and San Francisco International Airport, and is expanding to include Hartsfield-Jackson Atlanta International Airport.
The CDC’s program, conducted in collaboration with XpresCheck and Ginkgo Bioworks, offers two types of free testing options. The first is a PCR test done on a pooled sample collected at the airport on arrival. A pooled test means several passengers’ samples are combined together and tested as a group. This approach enables efficient large-scale testing of many passengers entering the country. The second option is an at-home specimen collection kit that passengers can take with them and mail back a sample collected three to five days after arrival into the United States for individualized PCR testing.
The CDC strongly encourages all international travelers to get tested three to five days after arrival in the United States. Through this program, results are provided to passengers and public health authorities to help interrupt the chain of transmission in US communities, and detect variants of concern entering the United States.
Nice AH action today.
Will the new variant send us to the moon?
MC $144 M
Liquidity and Financial Condition As of September 30, 2021, the Company had cash and cash equivalents, excluding restricted cash, of $109.2 million, and total current assets of $113.1 million and total current liabilities of $17.2 million reflecting strong working capital.
.....................,../..//
......................./..//
.....................,/..//
...................../..//
............./´¯/'... '/´¯`•¸
........../'/.../..../......./¨¯\
........('(...´(..........,~/'...')
.........\.......... .......\/..../
..........''...\.......... _.•´
............\.............(
..............\.............\
MC $ 150 milion
houston we have a problem
Strong testing numbers, concurrent with the resumption of travel, have enabled XpresCheck to vastly surpass our expectations to-date. We firmly believe that COVID-19 testing at major U.S. airports will remain an important part of travel, especially international travel, for the foreseeable future. This is due to the emergence of highly contagious COVID-19 variants, such as Delta, along with break-through vaccination infections. Our $2 million Centers for Disease Control and Prevention (“CDC”) pilot program, which is not reflected in these quarterly financials, is also showing positive results and we expect to recognize approximately 75% of the revenue during this fourth quarter. We also anticipate that this CDC program will be expanded.
Tic toc
Record Quarterly Revenue of $26.8 Million
Record Net Income of $5.6 Million
On Track for Record Year of Revenue and Earnings
Strong Liquidity Position with Unrestricted Cash Balance Increasing to $109.2 Million
Breaking 1.90 now, usual up and down expected, but $2 can't be far behind in any case.
$XSPA
Stock Repurchase Program
15.000.000 shares
Good
We got government contract time to trade this higher !!!
Can't understand why this room is so quiet, when this room
https://t.me/Xspartans20
is much, much busier with longs working together positively.
$XSPA
You still a virgin or what?
The chatter will come
I was expecting to see more chatter here too. XSPA has been moving the last few days, and I think we will see the PPS climb more in the next few weeks.
Thought there would be more chatter here. The upside potential has increased, especially with inclusion on Russell MicroCap even though not official until the 25th I guess, but I expect some movement up until then and beyond.
This will help if we can get more members on board, even if you're in as much as you can be, please let anyone else know about this>
https://t.me/XspaShortSqueeze
Said it once, say it again, go to>
https://t.me/XspaShortSqueeze
$XSPA is on the list to be added to Russell Microcap® Index this month>
https://content.ftserussell.com/sites/default/files/russell_microcap_additions_-_2021.pdf
This should be looked at...
https://t.me/XspaShortSqueeze
$XSPA
This aged well ??
What shouldn’t you sell may be a better question.
Followers
|
540
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
68424
|
Created
|
03/13/11
|
Type
|
Free
|
Moderators |
Forms New Business Unit XpresTest
In Discussions for Initial Testing with Three Major Airports
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today provided an update on recent discussions with local airport authorities and healthcare partners so that it may begin providing screening and testing for novel coronavirus (“COVID-19”) at U.S. airports. COVID-19 screening and testing would be conducted by converting select existing spa locations for this purpose on an interim basis and over time, potentially adding separate, standalone airport locations as testing sites.
XpresSpa’s U.S. airport real estate portfolio consists of 46 locations across 23 airports that are ready to be reactivated and redeployed in short order, subject to the approval of local airport authorities. The Company’s global spas are temporarily closed due to recent local government mandates categorizing its traditional services as “non-essential services”.
Since March 19, 2020, XpresSpa has been advancing discussions with healthcare partners to develop a model for COVID-19 screening and testing in U.S. airports as a much-needed public service. The Company has also recently filed paperwork in the State of Delaware to form a new business unit to administer such screening and testing capabilities, XpresTest, Inc., as a wholly-owned subsidiary of XpresSpa Group, Inc.
While nothing definitive has yet been finalized, XpresSpa is currently in discussions with three major airports, JFK International Airport, Hartsfield-Jackson Atlanta International Airport and Chicago O'Hare International Airport to pilot COVID-19 screening and testing for airline employees, contractors and workers, concessionaires and their employees, TSA agents, and U.S. Customs and Border Protection agents. The Company is also in the process of recruiting a medical director who would work alongside healthcare officials to help design safe and compliant protocols and train employees.
Doug Satzman, Chief Executive Officer, XpresSpa said, “We are moving forward with our public and private relationships to make COVID-19 screening and testing in U.S. airports a reality and hopefully will be able to begin pilot testing shortly for the benefit and protection of our fellow citizens. Since the onset of this pandemic, we have thought that we can and should play a significant role within the travel sector in the fight against COVID-19 and other highly contagious diseases in the future given our airport relationships, infrastructure, workforce with TSA clearance and strong desire to keep everyone safe.”
The Company recently announced its partnership with Relevant Healthcare. Relevant Healthcare is currently offering clinical diagnostic testing for COVID-19 through its contracts with Laboratory Corporation of America® (“LabCorp”) and Quest Diagnostics™ (“Quest”) to support full COVID-19 RT-PCR testing. In addition, the Company is also in active discussions with [Aytu BioScience (NASDAQ: AYTU; “Aytu”)], a specialty pharmaceutical company, and marketer of a COVID-19 IgG/IgM Rapid Test, and [Henry Schein Medical (“Henry Schein”)], the world’s largest distributor of health care solutions to office-based dental and medical professionals, and the developer of the Standard Q COVID-19 test, to deploy their respective rapid antibody blood testing solutions.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |